Sri Lanka has ordered 13.5 million Oxford AstraZeneca coronavirus vaccines in addition to the 500,000 doses gifted by India, and the country may not use Chinese vaccines in the second phase of immunisation, a government spokesman said on Tuesday.
Ramesh Pathirana, who is also the Minister of Plantations, said Sri Lanka is likely to go only with the AstraZeneca vaccines for the second phase of vaccination as the Chinese and Russian vaccines are not ready yet.
"The Chinese vaccine has not submitted the papers relating to phase three trials, said Pathirana.
For the first round of vaccinations, the government has placed an order for 10 million doses of AstraZeneca vaccine from the Serum Institute of India at a cost of USD 52.5 million and a further 3.5 million doses directly from AstraZeneca Institute of UK under the COVAX programme, the spokesman said.
India gifted 500,000 doses of the same vaccine which kicked off Sri Lanka's vaccine rollout in late January.
Sri Lankan President Gotabaya Rajapaksa thanked India last month for its generosity after he received 500,000 doses of Covishield vaccine donated by the country under the ''Neighbourhood First'' policy.
The government will be directed by the best medical advice on when the second dose should be given, Pathirana said, adding that although initially it was believed that the booster jab should be given after four weeks.
In recent weeks, health experts have said that delaying the second dose by three months could increase the efficacy of the vaccine.
Last month, India announced it will send COVID-19 vaccines under grant assistance to Sri Lanka and seven other countries - Bhutan, the Maldives, Bangladesh, Nepal, Myanmar and Seychelles, Afghanistan and Mauritius.
India is one of the world's biggest drug-makers and an increasing number of countries have already approached it for procuring coronavirus vaccines.
Sri Lanka has recorded more than 80,500 coronavirus cases so far with 450 deaths.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU